Drug Company Will Buy Up to $700 Million in BNB After Coin Hits All-Time High
Windtree Therapeutics has said it is raising another $520 million to buy up BNB, the fifth-largest digital coin, to put on its balance sheet.
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
Why this matters
This altcoin story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on DecryptRelated market context
BlackRock’s IBIT buys $195.6 million of Bitcoin in a day, $1.57 billion over the past month
BlackRock's significant Bitcoin acquisitions via IBIT highlight a shift towards institutional investment in regulated crypto produ...
El Salvador’s Bitcoin stash sits at $618 million despite IMF strings
El Salvador's Bitcoin strategy highlights the complexities of balancing national financial autonomy with international loan condit...
Powerus tokenized stock PUSA hits $8 million in volume on Solana in four hours
The rapid trading volume of $PUSA on Solana highlights the growing appeal and potential of tokenized stocks for 24/7 global market...
Stablecoin issuers have replaced 40% of China’s lost US Treasury demand
Stablecoin issuers are emerging as a new source of demand for US government debt as foreign official holdings lose ground. Tether...
Bitcoin briefly hits $87K as weak US jobs data sends bond yields lower
Bitcoin climbed after weaker-than-expected payrolls pushed Treasury yields lower, but order-book resistance kept BTC from reaching...
Bitcoin (BTC) Price Today: 2028 Halving Cycle and BlackRock ETF Inflow Signal Long-Term Rally
Recent market data also show that Bitcoin buyers have absorbed a key sell wall around $85,000, reducing one source of near-term re...